Tag: Prescription Drugs
FDA Sends 100 Cease-and-Desist Letters in Crackdown on DTC Drug Advertisements
Additionally, the agency is eliminating the 'adequate provision' loophole that allowed pharmaceutical companies to list complete risks separately
FDA Approves Inlexzo for Bladder Cancer
First and only drug releasing system is indicated for patients with BCG-unresponsive non-muscle-invasive bladder cancer seeking bladder preservation
FDA Releases Guidance to Promote Nonopioid Alternatives for Chronic Pain
New guidance aims to increase nonopioid choices for chronic pain while combating misuse
Half of Women With Hyperemesis Gravidarum Report Major Impacts on Life
Antiemetic use and outcomes vary widely for this group of patients
WHO Updates List of Essential Medicines to Include GLP-1s
PD-1/PD-L1 immunotherapies for several metastatic cancers also made the list of essential drugs
2000 to 2023 Saw Rise in Pediatric Exposure to Medications, Supplements
Overall rate of exposure for children aged 6 to 12 years up by 53.8 percent; >300 percent increase in exposure linked to self-harm, suicidal intent
Baxdrostat Reduces Seated Systolic BP in Uncontrolled, Resistant Hypertension
Addition of baxdrostat to background therapy results in significantly lower seated systolic blood pressure
FDA Expands Use of Vonvendi for Von Willebrand Disease
The recombinant treatment is now approved for prophylactic use in adults and for treating bleeding episodes and perioperative use in children
Industry Payments Common Among Neurologists Prescribing MS Drugs
Nearly 80 percent of neurologists received payments; higher prescription volumes linked to higher receipt of payments
Azelastine Nasal Spray Reduces Risk for SARS-CoV-2 Infection
Azelastine also shows increase in mean time to SARS-CoV-2 infection, reduction in symptomatic infections
